520 related articles for article (PubMed ID: 12553888)
1. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
Bravo SA; Lamas MC; Salamón CJ
J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
3. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
[TBL] [Abstract][Full Text] [Related]
4. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
5. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium.
Al-Taani BM; Tashtoush BM
AAPS PharmSciTech; 2003; 4(3):E43. PubMed ID: 14621975
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
Reza MS; Quadir MA; Haider SS
J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
[TBL] [Abstract][Full Text] [Related]
7. Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets.
Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Johnson M; Leroux JC
Pharm Dev Technol; 2003; 8(4):335-48. PubMed ID: 14601958
[TBL] [Abstract][Full Text] [Related]
8. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
9. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
Avachat A; Kotwal V
AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
[TBL] [Abstract][Full Text] [Related]
11. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
Wang MY; Yang YP; Chang JB; Guo MT
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac.
Rahmouni M; Chouinard F; Nekka F; Lenaerts V; Leroux JC
Eur J Pharm Biopharm; 2001 May; 51(3):191-8. PubMed ID: 11343882
[TBL] [Abstract][Full Text] [Related]
13. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release.
Al-Hanbali OA; Hamed R; Arafat M; Bakkour Y; Al-Matubsi H; Mansour R; Al-Bataineh Y; Aldhoun M; Sarfraz M; Dardas AKY
Pak J Pharm Sci; 2018 Jan; 31(1(Suppl.)):345-351. PubMed ID: 29386164
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK
AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050
[TBL] [Abstract][Full Text] [Related]
16. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
17. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
19. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices.
Levina M; Rajabi-Siahboomi AR
J Pharm Sci; 2004 Nov; 93(11):2746-54. PubMed ID: 15389670
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
